Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients

Completed · Phase 2 · Has a placebo group

Conditions studied: Alcoholism

In brief

The purpose of the study will be to evaluate the efficacy of mecamylamine in reducing alcohol consumption in smoking and non-smoking alcohol dependent patients. We hypothesize that mecamylamine will result in a greater reduction of alcohol consumption than placebo. We further hypothesize that mecamylamine will be effective in reducing both alcohol consumption and smoking in a subset of alcoholics who also smoke.

Key facts

Study ID
NCT00342563
Run by
Yale University
People needed
136
Starts
2004-05-01
Expected to finish
2015-07-01
Last updated by the study team
2019-06-04

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.